Financing malaria

Area of Science:

• Global Health
• Infectious Disease Control
• Health Economics

Background:

• International financing for malaria control has plateaued since 2010, hindering elimination efforts.
• Both donor and recipient countries face significant fiscal constraints, limiting funding expansion.
• Past declarations, like the Abuja declaration, have not yielded sufficient increases in malaria funding.

Purpose of the Study:

• To analyze the challenges and opportunities in financing malaria elimination.
• To identify strategies for improving the impact of international health financing.
• To explore the role of domestic financing and health system strengthening in achieving malaria elimination.

Main Methods:

• Analysis of international financing trends in malaria control.
• Review of fiscal constraints in developed and developing countries.
• Examination of case studies from countries that have eliminated malaria (Sri Lanka, El Salvador, China).

Main Results:

• Increased international financing is unlikely due to global fiscal constraints.
• Emerging economies like China may offer new financing avenues, but require shifts in global financial architecture.
• Improving the efficiency of existing funds is crucial, addressing transaction costs and potential misalignments with national priorities.
• Domestic spending, often underestimated, significantly exceeds international contributions.
• Early and widespread treatment, supported by robust health systems prioritizing universal access, is critical for sustained elimination.

Conclusions:

• Malaria elimination requires a paradigm shift beyond simply increasing funding.
• Enhanced domestic resource mobilization and efficient utilization of available funds are paramount.
• Strengthening health systems to ensure equitable access to services is essential for achieving and sustaining malaria elimination.
• Greater alignment of international funding with the preferences and priorities of affected populations and local health systems is needed.